Conditions: Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Exocrine Pancreatic Cancer; Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: tisotumab vedotin
Sponsors: Seattle Genetics, Inc.; Genmab
Not yet recruiting
https://ift.tt/2GLIXPI
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου